GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
52.21
-4.06 (-7.22%)
At close: Jun 5, 2026, 4:00 PM EDT
52.50
+0.29 (0.56%)
After-hours: Jun 5, 2026, 5:14 PM EDT

GeneDx Holdings Stock Forecast

Stock Price Forecast

The 9 analysts that cover GeneDx Holdings stock have a consensus rating of "Strong Buy" and an average price target of $77, which forecasts a 47.48% increase in the stock price over the next year. The lowest target is $50 and the highest is $100.

Price Target: $77 (+47.48%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$50$77$75$100
Change-4.23%+47.48%+43.65%+91.53%

Analyst Ratings

The average analyst rating for GeneDx Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy778888
Buy111111
Hold110000
Sell000000
Strong Sell000000
Total999999

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Buy
Maintains
$85
BuyMaintains$85+62.80%May 14, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$130
BuyMaintains$130+148.99%May 5, 2026
BTIG
BTIG
Buy
Reiterates
$170$90
BuyReiterates$170$90+72.38%May 5, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$100$70
BuyReiterates$100$70+34.07%May 5, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$100$75
BuyReiterates$100$75+43.65%May 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
478.38M
from 427.54M
Increased by 11.89%
Revenue Next Year
594.90M
from 478.38M
Increased by 24.36%
EPS This Year
0.11
from 1.40
Decreased by -92.14%
EPS Next Year
1.23
from 0.11
Increased by 1,019.32%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
212.20M234.69M202.57M305.45M427.54M478.38M
Revenue Growth
18.33%10.60%-13.69%50.79%39.97%11.89%
Gross Profit
-16.60M-26.75M90.15M194.45M298.18M332.63M
Gross Margin
-7.82%-11.40%44.50%63.66%69.74%69.53%
Operating Income
-446.15M-457.51M-170.06M-23.16M-11.67M5.60M
Net Income
-245.39M-548.98M-175.77M-52.29M-21.02M-89.75M
EPS
----1.400.11
EPS Growth
----460.67%-92.14%
Forward PE
---190.96-474.64
Free Cash Flow
-43.99M-172.97M-124.34M-1.16M38.06M-29.50M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High483.3M
Avg478.4M
Low472.1M

Revenue Growth

Revenue Growth202620272028
High
13.0%
Avg
11.9%
Low
10.4%

EPS Forecast

EPS202620272028
High-
Avg0.11
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
-92.1%
Low-